Which closed-end funds own Contra Vigil Neuroscie?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $18.8K. Security type: OTHER. Country: United States. CUSIP 926CVR010 · ISIN US926CVR0106 · ticker VIGL.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GDL GDL Fund | U.S. Equity | 0.01% | $12.3K | 245,000 sh | $122M | 21.5% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.00% | $6.6K | 131,344 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: VIGIL NEUROSCIENCE INC.
Issuer-level search for “VIGL” → · Compare two funds’ portfolios →